Literature DB >> 28992267

White blood cell fractions correlate with lesions of diabetic kidney disease and predict loss of kidney function in Type 2 diabetes.

Kevin M Wheelock1, Pierre-Jean Saulnier1,2, Stephanie K Tanamas1, Pavithra Vijayakumar1, E Jennifer Weil1, Helen C Looker1, Robert L Hanson1, Kevin V Lemley3, Berne Yee4, William C Knowler1, Samy Hadjadj2, Behzad Najafian5, Michael Mauer6, Robert G Nelson1.   

Abstract

Background: Inflammation linked to diabetic kidney disease (DKD) may affect white blood cell (WBC) counts and differentials. We examined the cross-sectional associations of total WBC count and WBC fractions with structural lesions of DKD in 108 Pima Indians with Type 2 diabetes who underwent research kidney biopsies. We also examined the longitudinal association of these WBC variables with renal function loss (RFL) in 941 Europeans with Type 2 diabetes from the SURDIAGENE study.
Methods: Associations of WBC variables with morphometric parameters were assessed by linear regression. RFL was defined as≥40% loss of estimated glomerular filtration rate from baseline. Associations with RFL were evaluated by Cox regression. Hazard ratios (HRs) were reported per standard deviation increment of each WBC variable.
Results: After multivariable adjustment, lymphocyte (r  = -0.20, P = 0.043) and eosinophil (r = 0.21, P = 0.032) fractions in the Pima Indians correlated with glomerular basement membrane width. Eosinophil fraction also correlated with glomerular filtration surface density (r  = -0.21, P = 0.031). Lymphocyte fraction (r = 0.25, P = 0.013), neutrophil fraction (r  = -0.23, P = 0.021) and the neutrophil:lymphocyte ratio (r  = -0.22, P = 0.024) correlated with percentage of normally fenestrated endothelial cells. During median follow-up of 4.5 years, 321 SURDIAGENE participants developed RFL. Lower lymphocyte fraction [HR = 0.67, 95% confidence interval (95% CI) 0.60-0.76] and higher neutrophil fraction (HR = 1.35, 95% CI 1.20-1.52), total WBC count (HR = 1.20, 95% CI 1.08-1.35) and neutrophil:lymphocyte ratio (HR = 1.44, 95% CI 1.28-1.62) each predicted RFL in this cohort. Conclusions: WBC fractions associate with morphometric lesions of DKD and predict RFL in individuals with Type 2 diabetes.

Entities:  

Mesh:

Year:  2018        PMID: 28992267     DOI: 10.1093/ndt/gfx231

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

Review 1.  Role of Kidney Biopsies for Biomarker Discovery in Diabetic Kidney Disease.

Authors:  Helen C Looker; Michael Mauer; Robert G Nelson
Journal:  Adv Chronic Kidney Dis       Date:  2018-03       Impact factor: 3.620

2.  Screening of Diabetic Nephropathy Progression-Related Genes Based on Weighted Gene Co-expression Network Analysis.

Authors:  Ling'an Yu; Haiying Tao
Journal:  Biochem Genet       Date:  2022-07-14       Impact factor: 2.220

3.  The analysis of risk factors for diabetic kidney disease progression: a single-centre and cross-sectional experiment in Shanghai.

Authors:  Wen Liu; Juan Du; Xiaoxu Ge; Xiaohong Jiang; Wenfang Peng; Nan Zhao; Lisha Shen; Lili Xia; Fan Hu; Shan Huang
Journal:  BMJ Open       Date:  2022-06-28       Impact factor: 3.006

4.  Development and validation of a predictive model for the progression of diabetic kidney disease to kidney failure.

Authors:  Yaqi Cheng; Jin Shang; Dong Liu; Jing Xiao; Zhanzheng Zhao
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

Review 5.  Pima Indian Contributions to Our Understanding of Diabetic Kidney Disease.

Authors:  Robert G Nelson; William C Knowler; Matthias Kretzler; Kevin V Lemley; Helen C Looker; Michael Mauer; William E Mitch; Behzad Najafian; Peter H Bennett
Journal:  Diabetes       Date:  2021-07-20       Impact factor: 9.337

6.  Neutrophil count as a reliable marker for diabetic kidney disease in autoimmune diabetes.

Authors:  Yao Yu; Qiuqiu Lin; Dewei Ye; Yanfei Wang; Binbin He; Yanhua Li; Gan Huang; Zhiguang Zhou; Yang Xiao
Journal:  BMC Endocr Disord       Date:  2020-10-22       Impact factor: 2.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.